Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment

Acute myeloid leukemia (AML) is a phenotypically and prognostically heterogeneous hematopoietic stem cell disease that may be cured in eligible patients with intensive chemotherapy and/or allogeneic stem cell transplantation (allo-SCT). Tremendous advances in sequencing technologies have revealed a...

Full description

Bibliographic Details
Main Authors: Christina Rautenberg, Ulrich Germing, Rainer Haas, Guido Kobbe, Thomas Schroeder
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:International Journal of Molecular Sciences
Subjects:
acute myeloid leukemia
allogeneic transplantation
relapse
maintenance
minimal residual disease
salvage therapy
Online Access:http://www.mdpi.com/1422-0067/20/1/228

Internet

http://www.mdpi.com/1422-0067/20/1/228

Similar Items